Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An update from SAI Life Sciences Ltd. ( (IN:SAILIFE) ) is now available.
Sai Life Sciences Ltd. has announced a closure of its trading window for designated persons and their immediate relatives starting April 1, 2026, in line with SEBI’s Prohibition of Insider Trading Regulations and the company’s internal code of conduct. The window will reopen 48 hours after the company discloses its audited standalone and consolidated financial results for the fourth quarter and full year ending March 31, 2026.
The move is a routine governance measure aimed at preventing insider trading ahead of the release of key financial information and underscores the company’s adherence to regulatory compliance standards. The date of the board meeting to approve these audited results will be communicated to the stock exchanges in due course, signaling that the forthcoming earnings announcement is the next key event for investors and other market participants.
More about SAI Life Sciences Ltd.
Sai Life Sciences Ltd. operates in the life sciences and pharmaceutical services industry, providing research, development and manufacturing support for drug discovery and development. The company serves global pharmaceutical and biotech clients from its facilities in Hyderabad, Telangana, reflecting a focus on integrated, end-to-end contract research and manufacturing services.
Average Trading Volume: 37,375
Technical Sentiment Signal: Strong Buy
Current Market Cap: 208.8B INR
Learn more about SAILIFE stock on TipRanks’ Stock Analysis page.